Drug
Exenatide Lar
Exenatide Lar: highest development phase Phase 2, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| Exenatide LAR NCT00103935 | Phase 2 | Type 2 Diabetes Mellitus |
Latest
No recent events.
Follow Exenatide Lar on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.